Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Morepen Laboratories Ltd. Capital/Financing Update 2024

Feb 22, 2024

59389_rns_2024-02-22_bbc9780a-e6f0-4f69-9103-a86f1fab84bf.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [92 x 841] intentionally omitted <==

==> picture [79 x 75] intentionally omitted <==

==> picture [159 x 37] intentionally omitted <==

Date: 22.02.2024

National Stock Exchange of India Ltd. Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai- 400 051 Symbol: MOREPENLAB

BSE Limited

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 500288

Sub: Outcome of the Board Meeting held on Thursday, February 22, 2024.

Dear Sir/ Madam,

This is with reference to our letter dated February 19, 2024, we wish to inform you that the Board of Directors of Morepen Laboratories Limited (the “ Company ”) (the “ Board ”), at its meeting held today, Thursday, February 22, 2024 ( commenced at 5.30 P.M. and concluded at 7.30 P.M.), has inter-alia approved the following:

  • (i) raising of funds by way of issuance of equity shares , convertible preference shares, and/ or debentures/ non-convertible debt instruments along with warrants/ convertible debentures/ securities and/ or any other equity based instrument(s) (collectively “ Securities ”), inter alia, through one or more qualified institutions placement (“QIP”) in accordance with Chapter VI of the SEBI ICDR Regulations, and / or through any other permissible mode, such number of Equity Shares of the face value of Rs. 2/- (Rupees Two Only) each for an aggregate amount not exceeding Rs. 350 Crore (Rupees Three Hundred Fifty Crore Only) as may be considered appropriate under applicable law, subject to such regulatory/statutory approvals as may be required and the approval of shareholders of the Company; and

  • (ii) approval for issuance of notice convening extraordinary general meeting to seek approval of the shareholders for the aforesaid issuance and ancillary actions by way of an extraordinary general meeting.

The details, as required to be disclosed under Regulation 30 read with SEBI circular no. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, are also enclosed as Annexure A .

We request you to kindly take this on record and consider the above in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.

Thanking you,

Yours faithfully,

For Morepen Laboratories Limited

Vipul Digitally signed Kumar by Vipul Kumar Srivastava Srivastav Date: 2024.02.22 a 19:56:47 +05'30'

Vipul Kumar Srivastava Company Secretary F-12148

Morepen Laboratories Limited

CIN NO. L24231 HP1984PLC006028

Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector-20, Gurugram, Haryana-122016, INDIA TEL.: +91 124 4892000, E-mail: [email protected], Website: www.morepen.com

Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA Tel.: +91 1795 266401-03, 244590, Fax: +91 1795 244591, E-mail: [email protected]

==> picture [92 x 841] intentionally omitted <==

==> picture [79 x 75] intentionally omitted <==

==> picture [159 x 37] intentionally omitted <==

Annexure A

The details as required to be disclosed under Regulation 30 read with SEBI circular no. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023:

==> picture [452 x 549] intentionally omitted <==

----- Start of picture text ----- S. No. Particulars Details1. Type of securities proposed to be issued Equity Shares, convertible preference shares,(viz., equity shares, convertibles, etc. and/ or debentures/ non-convertible debtinstruments along with warrants/ convertibledebentures/ securities and/ or any other equitybased instrument(s) (hereinafter referred to as“ Securities ”) or any combination thereof, inaccordance with applicable law, in one or moretranches.2. Type of issuance (further public offering, Qualified institution placements (“QIP”) inrights issue, depository receipts (ADR / accordance with the provisions of Chapter VIGDR), qualified institutions placement, of the Securities and Exchange Board of Indiapreferential allotment etc.) (Issue of Capital and DisclosureRequirements) Regulations, 2018, Section 42and other applicable provisions of theCompanies Act, 2013, the Companies(Prospectus and Allotment of Securities)Rules, 2014 and other applicable laws, orthrough any other permissible mode and/orcombination thereof as may be consideredappropriate under applicable law.3. Total number of securities proposed to be Up to an aggregate amount not exceeding Rs.issued or the total amount for which the 350 Crore (Rupees Three Hundred Fifty Croresecurities will be issued (approximately) Only) or an equivalent amount thereof(inclusive of such premium as may be fixed onsuch Securities) at such price or prices as maybe permissible under applicable law.4. In case of preferential issue, the listed Not Applicableentity shall disclose the followingadditional details to the stock exchange(s)5. In case of bonus issue the listed entity shall Not Applicabledisclose the following additional details tothe stock exchange(s)6. In case of issuance of depository receipts Not Applicable(ADR/GDR) or FCCB the listed entityshall disclose following additional detailsto the stock exchange(s)----- End of picture text -----

Morepen Laboratories Limited

CIN NO. L24231 HP1984PLC006028

Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector-20, Gurugram, Haryana-122016, INDIA TEL.: +91 124 4892000, E-mail: [email protected], Website: www.morepen.com

Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA Tel.: +91 1795 266401-03, 244590, Fax: +91 1795 244591, E-mail: [email protected]

==> picture [92 x 841] intentionally omitted <==

==> picture [79 x 75] intentionally omitted <==

==> picture [159 x 37] intentionally omitted <==

7. In case of issuance of debt securities orother non-convertible securities the listedentity shall disclose following additionaldetails to the stock exchange(s) Not Applicable
8. Any cancellation or termination ofproposalforissuanceofsecuritiesincluding reasons thereof. Not Applicable

Morepen Laboratories Limited

CIN NO. L24231 HP1984PLC006028

Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector-20, Gurugram, Haryana-122016, INDIA TEL.: +91 124 4892000, E-mail: [email protected], Website: www.morepen.com

Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA Tel.: +91 1795 266401-03, 244590, Fax: +91 1795 244591, E-mail: [email protected]